Excellent point. That is why I got in this stock, because of recaf's ability to detect cancer early. While it is important to know where the cancer is, such a test is like a car's engine light coming on to tell you something is wrong with your car so that you can bring it in and find out what is wrong. The earlier you know something is wrong the easier and cheaper it is to fix it. While it would be nice to have a "magic bullet", as an investor I am quite content to be the owner of the "engine light" at this point, and I am hoping that we can get it to market sooner rather than later. Once the test is out, the company can continue on its vertical integration strategy or whatever one wishes to call it. Besides, it will have a lot more money to do so if it can sell a few tests. Remember, baby steps Dr. Moro, baby steps.